ReWalk Robotics Ltd (NASDAQ:RWLK)’s share price gapped down before the market opened on Monday . The stock had previously closed at $1.55, but opened at $1.35. ReWalk Robotics shares last traded at $1.15, with a volume of 4143200 shares changing hands.

RWLK has been the subject of several research reports. Zacks Investment Research upgraded shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a research report on Thursday, November 9th. Canaccord Genuity decreased their target price on shares of ReWalk Robotics from $4.00 to $3.00 and set a “buy” rating for the company in a report on Friday, August 4th. Oppenheimer Holdings, Inc. set a $4.00 target price on shares of ReWalk Robotics and gave the stock a “buy” rating in a report on Friday, August 4th. Finally, Jefferies Group LLC decreased their target price on shares of ReWalk Robotics from $8.00 to $5.00 and set a “buy” rating for the company in a report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $3.00.

The company has a debt-to-equity ratio of 7.46, a current ratio of 2.02 and a quick ratio of 1.65.

ReWalk Robotics (NASDAQ:RWLK) last announced its earnings results on Thursday, November 2nd. The medical device company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.32) by $0.10. ReWalk Robotics had a negative net margin of 346.14% and a negative return on equity of 568.25%. The company had revenue of $1.70 million during the quarter, compared to analysts’ expectations of $1.63 million. During the same period last year, the company posted ($0.62) earnings per share. The business’s revenue for the quarter was up 21.4% on a year-over-year basis. equities research analysts forecast that ReWalk Robotics Ltd will post -1.14 EPS for the current year.

Several institutional investors and hedge funds have recently made changes to their positions in RWLK. Advisor Group Inc. boosted its holdings in shares of ReWalk Robotics by 1,495.6% in the third quarter. Advisor Group Inc. now owns 181,900 shares of the medical device company’s stock worth $264,000 after buying an additional 170,500 shares during the period. Essex Investment Management Co. LLC boosted its holdings in shares of ReWalk Robotics by 328.7% during the third quarter. Essex Investment Management Co. LLC now owns 156,981 shares of the medical device company’s stock worth $228,000 after purchasing an additional 120,362 shares during the period. Finally, Renaissance Technologies LLC boosted its holdings in shares of ReWalk Robotics by 61.7% during the first quarter. Renaissance Technologies LLC now owns 78,600 shares of the medical device company’s stock worth $165,000 after purchasing an additional 30,000 shares during the period. Institutional investors own 4.21% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.thecerbatgem.com/2017/11/20/rewalk-robotics-ltd-rwlk-shares-gap-down-to-1-35.html.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.

Receive News & Stock Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related stocks with our FREE daily email newsletter.